Edward Tad Stewart, MBA

Tad is a experienced biopharma business and corporate development executive. He has played an integral strategic role in funding and scaling biotechnology companies from early research to clinical development and through commercial launch.  Prior to Matrisome Bio, Tad served in leadership roles with several companies, including Ribon Therapeutics, GRO Biosciences, Crescendo Biologics and Merrimack Pharmaceuticals.